Skip to content

Comparison of the effectiveness of allopurinol and placebo in reducing depressive symptoms in patients with major depressive disorder

Comparison of the effectiveness of allopurinol and placebo in reducing depressive symptoms in patients with major depressive disorder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201508277373N6
Enrollment
70
Registered
2015-12-03
Start date
2015-07-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Major depression. Condition 2: Major depression. Mild depressive episode Moderate depressive episode

Interventions

Intervention 1: The intervention group clinical citalopram 40 mg for 6 weeks plus allopurinol 300 mg daily receive. Intervention 2: Clinical citalopram 40 mg daily for 6 weeks plus a control group tha
Treatment - Drugs
The intervention group clinical citalopram 40 mg for 6 weeks plus allopurinol 300 mg daily receive.
Clinical citalopram 40 mg daily for 6 weeks plus a control group that received placebo.

Sponsors

Arak University of Medical Sceinces
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18 to 65 years, diagnosed with major depression based on clinical interviews and diagnostic criteria for DSM V; normal blood levels of uric acid and liver enzymes (ALT, AST) Exclusion criteria: Serious psychiatric disorders, personality disorders; Taking several drugs simultaneously; severe physical illness; Sensitivity to allopurinol

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hamilton Square. Timepoint: Before the intervention, 4 to 6 weeks, end of study. Method of measurement: Hamilton questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ranjbaran Farideh

Arak University of Medical sceinces

faridehranjbaran@yahoo.com; Mjamilian@yahoo.com; rahenorayaneh@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026